​

Align (ALGN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ALGN Stock Forecast

Align (ALGN) stock forecast, based on 33 Wall Street analysts, predicts a 12-month average price target of $182.00, with a high of $210.00 and a low of $154.00. This represents a 33.91% increase from the last price of $135.91.

$100 $150 $200 $250 $300 $350 High: $210 Avg: $182 Low: $154 Last Closed Price: $135.91

ALGN Stock Rating

Align stock's rating consensus is Buy, based on 33 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 23 Buy (69.70%), 8 Hold (24.24%), 2 Sell (6.06%), and 0 Strong Sell (0.00%).

Buy
Total 33 0 2 8 23 Strong Sell Sell Hold Buy Strong Buy

ALGN Price Target Upside V Benchmarks

TypeNameUpside
StockAlign33.91%
SectorHealthcare Stocks 13.55%
IndustryMedical Device Stocks14.97%

Price Target Trends

1M3M12M
# Anlaysts-210
Avg Price Target-$182.00$246.40
Last Closing Price$135.91$135.91$135.91
Upside/Downside-33.91%81.30%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 25286-117
Aug, 25197-118
Jul, 25395-118
Jun, 25386-118
May, 25386-118
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 31, 2025Mizuho Securities$210.00$203.573.16%54.51%
Jul 31, 2025Morgan Stanley$154.00$142.508.07%13.31%
Oct 24, 2024Jonathan BlockStifel Nicolaus$275.00$207.6632.43%102.34%
Oct 24, 2024Jason BednarPiper Sandler$275.00$221.0624.40%102.34%
Oct 24, 2024Michael ChernyLeerink Partners$235.00$207.6613.17%72.91%
Oct 24, 2024Elizabeth AndersonEvercore ISI$250.00$207.6620.39%83.95%
Oct 17, 2024Jason BednarPiper Sandler$285.00$216.0531.91%109.70%
Oct 11, 2024Jonathan BlockStifel Nicolaus$285.00$229.6524.10%109.70%
Oct 10, 2024Charles Perron-PicheGoldman Sachs$225.00$231.05-2.62%65.55%
Oct 08, 2024Elizabeth AndersonEvercore ISI$270.00$234.8514.97%98.66%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 18, 2025Piper SandlerOverweightOverweighthold
Nov 04, 2024NeedhamHoldHoldhold
Oct 24, 2024Leerink PartnersMarket PerformMarket Performhold
Oct 17, 2024Piper SandlerOverweightOverweighthold
Oct 10, 2024B. Riley SecuritiesBuyinitialise
Oct 10, 2024Sandler O'NeilUnderperformUnderperformhold
Oct 10, 2024NeedhamHoldinitialise
Oct 08, 2024Evercore ISIOutperformOutperformhold
Sep 13, 2024Sandler O'NeillBuyBuyhold
Sep 13, 2024Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$0 $5 $10 $15 $20 $25 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$22.55$9.78$4.62$5.82$5.63---
Avg Forecast$4.75$11.15$7.03$8.37$9.33$10.19$11.59$13.50
High Forecast$4.85$11.39$7.28$8.41$9.37$10.46$12.63$13.62
Low Forecast$4.63$10.88$6.89$8.31$9.27$10.01$10.50$13.38
Surprise %374.74%-12.29%-34.28%-30.47%-39.66%---

Revenue Forecast

$2B $3B $3B $4B $4B $5B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$2.47B$3.95B$3.73B$3.86B$4.00B---
Avg Forecast$2.43B$3.95B$3.73B$3.84B$4.00B$4.23B$4.55B$4.93B
High Forecast$2.47B$4.01B$3.83B$3.85B$4.01B$4.29B$4.58B$4.97B
Low Forecast$2.38B$3.87B$3.67B$3.75B$3.99B$4.16B$4.52B$4.88B
Surprise %1.84%0.15%0.15%0.71%-0.03%---

Net Income Forecast

$0 $600M $1B $2B $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$1.78B$772.02M$361.57M$445.05M$421.36M---
Avg Forecast$2.06B$662.52M$643.33M$445.05M$713.78M$783.88M$885.37M$1.03B
High Forecast$2.54B$795.02M$771.99M$534.06M$717.61M$801.26M$966.97M$1.04B
Low Forecast$1.57B$530.02M$514.66M$356.04M$709.95M$766.49M$803.77M$1.02B
Surprise %-13.74%16.53%-43.80%--40.97%---

ALGN Forecast FAQ

Is Align stock a buy?

Align stock has a consensus rating of Buy, based on 33 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 23 Buy, 8 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Align is a favorable investment for most analysts.

What is Align's price target?

Align's price target, set by 33 Wall Street analysts, averages $182 over the next 12 months. The price target range spans from $154 at the low end to $210 at the high end, suggesting a potential 33.91% change from the previous closing price of $135.91.

How does Align stock forecast compare to its benchmarks?

Align's stock forecast shows a 33.91% upside, outperforming the average forecast for the healthcare stocks sector (13.55%) and outperforming the medical device stocks industry (14.97%).

What is the breakdown of analyst ratings for Align over the past three months?

  • September 2025: 11.76% Strong Buy, 47.06% Buy, 35.29% Hold, 0% Sell, 5.88% Strong Sell.
  • August 2025: 5.56% Strong Buy, 50.00% Buy, 38.89% Hold, 0% Sell, 5.56% Strong Sell.
  • July 2025: 16.67% Strong Buy, 50.00% Buy, 27.78% Hold, 0% Sell, 5.56% Strong Sell.

What is Align’s EPS forecast?

Align's average annual EPS forecast for its fiscal year ending in December 2025 is $10.19, marking a 80.99% increase from the reported $5.63 in 2024. Estimates for the following years are $11.59 in 2026, and $13.5 in 2027.

What is Align’s revenue forecast?

Align's average annual revenue forecast for its fiscal year ending in December 2025 is $4.23B, reflecting a 5.69% increase from the reported $4B in 2024. The forecast for 2026 is $4.55B, and $4.93B for 2027.

What is Align’s net income forecast?

Align's net income forecast for the fiscal year ending in December 2025 stands at $783.88M, representing an 86.03% increase from the reported $421.36M in 2024. Projections indicate $885.37M in 2026, and $1.03B in 2027.